IONIS PHARMACEUTICALS INC (IONS) Stock Analyst Ratings
USA - NASDAQ:IONS - US4622221004 - Common Stock
71.5 USD
-0.14 (-0.2%)
72 USD
+0.5 (+0.7%)
ChartMill assigns a Buy % Consensus number of 82% to IONS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 74.51. This target is 4.21% above the current price.
IONS was analyzed by 31 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about IONS.
In the previous month the buy percentage consensus was at a similar level.
IONS was analyzed by 31 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-08 | Needham | Maintains | Buy -> Buy |
| 2025-10-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-10-08 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-10-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-10-06 | Stifel | Maintains | Hold -> Hold |
| 2025-09-26 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2025-09-23 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-23 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-23 | B of A Securities | Maintains | Buy -> Buy |
| 2025-09-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-03 | BMO Capital | Upgrade | Market Perform -> Outperform |
| 2025-09-03 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-03 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-09-03 | Citigroup | Maintains | Buy -> Buy |
| 2025-09-02 | Needham | Maintains | Buy -> Buy |
| 2025-09-02 | Jefferies | Maintains | Buy -> Buy |
| 2025-09-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-25 | Needham | Reiterate | Buy -> Buy |
| 2025-08-25 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-08-22 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-22 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-22 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-22 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-12 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-31 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-07-31 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |